title: Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
authors.affiliation: Schieffelin Leprosy Research & Training Centre, Karigiri, India.
authors.forename: E J
authors.initials: EJ
authors.lastname: Darius
authors.forename: A
authors.initials: A
authors.lastname: Selvasekar
authors.forename: M N
authors.initials: MN
authors.lastname: Mani
authors.forename: K
authors.initials: K
authors.lastname: Jesudasan
mesh_terms: D000038:Abscess / Q000188:drug therapy / Q000209:etiology*; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015441:Leprosy, Tuberculoid / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D009443:Neuritis / Q000188:drug therapy / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D014459:Ulnar Nerve
chemical_list: D000893:Anti-Inflammatory Agents; D007917:Leprostatic Agents; D013256:Steroids; D011239:Prednisolone